Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-29

Clinical Trial Update: Evaluation of Methylprednisolone or Ibuprofen on Efficacy of Nerve Blocks With Symptomatic Irreversible Pulpitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating methylprednisolone or ibuprofen for efficacy of nerve blocks in irreversibile pulpitis; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)
  • METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Walter Reed National Military Medical Center | Conditions: Irreversible Pulpitis | Phase 3 | Status: TERMINATED